PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Easyhaler (Salbutamol) - Asthma
PAD Profile : Easyhaler (Salbutamol) - Asthma
Keywords :
SABAs, bronchodilators, adrenoreceptor agonists, short acting beta agonist, respiratory, asthmatics, reliever inhalers
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Fostair NEXThaler (beclometasone and formoterol)
- Montelukast
- Theophylline
- Clenil Modulite (beclometasone)
- Easyhaler (Beclometasone)
- Easyhaler (Budesonide)
- Fostair (Beclometasone and formoterol)
- Budelin Novolizer (budesonide)
- Dupilumab
- Airflusal (Salmeterol/Fluticasone) MDI
- Aerivio Spiromax (Fluticasone/Salmeterol) DPI
- Ventolin Accuhaler (salbutamol)
- Sereflo Ciphaler (Salmeterol / Fluticasone) DPI
- Campona Airmaster (Salmeterol / Fluticasone) DPI
- Salbutamol
- Terbutaline sulphate
- Budesonide
- Salamol Easi-Breathe
Other Indications
- Asthma
- Delay of premature labour
- Asthma
- Respiratory disease indications
- Respiratory disease indications
- Asthma
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
02 November 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Salbutamol Easyhaler or Ventolin Accuhaler are the locally preferred dry powder devices
Salamol MDI is the locally preferred salbutamol MDI device and should be used with a spacer device.
It has a lower carbon footprint than the large volume MDIs such as Ventolin.
Branded prescribing of inhaler devices is recommended.
See guidelines below
Associated BNF Codes
03. Respiratory System
03.01.01. Adrenoceptor agonists